Member Info for Newuncle

Laura,

Looks good to me.

Chiddy,

The overall direction of travel is positive, I am happy to let traders do thing short term and move it either way, MMs are not having my shares.

Chiddy,

Wouldn't that be nice to see.

Bit more patience for that, in the mean time this like the West Brom of shares, very much a boing boing stock, I think that will change dramatically with the next update.

IMO sellers are just traders exiting and bagging quick profits fwiw. There is also the fact that 2p level is a glass ceiling that keeps being tested and failing as traders take their money off the table, that should change once they have finished. For now it could just bounce around these levels but unless you want to lock in profits it's just noise. Hope our new COO might put his hand in his pocket soon.

The predictive capability of Physiomics' technologies have been confirmed by over 100 projects, involving over 40 targets and 70 drugs, and has worked with clients such as Merck KGaA, Astellas, Merck & Co and Bicycle Therapeutics.

Plenty of new opportunities ahead then?

The Company is actively considering how it could expand its business beyond its current consulting services areas as follows:

· Expansion into therapy areas other than cancer

· Expansion into consulting areas adjacent to those currently serviced

· Application of the Company's capabilities (e.g. machine learning and other AI related areas) to pharmaceutical R&D

Any risk of further placings or was that last one enough?

Use of Proceeds

In order to further develop its business and accelerate growth, the Company targeted a raise of around £300,000 with the intention of using the net proceeds of the Fundraise towards activities including:

· Further expansion and diversification of its client base;

· Expansion of its consulting business into the adjacent area of pharmaceutical biostatistics services; and

· Exploration of opportunities around its personalised oncology software offering.

What I really like about PYC is that they are in a niche and high growth market/sector but have no risk that is usually associated with a pharma type companies ir endless trials and approvals required. Their products are tried and tested and they work ie repeat orders are evidence of that. Customer base is expanding, contracts coming through the doors and have been able to now attract a high calibre COO. Looks pretty good to me, so what am I missing if there is a case against the company, note I said the company, not other posters.

Given PYC recent RNS history not long to wait.

Reckon the next RNS will be the one that gets these rerated.

Right now that trolls are gone let's get back to stuff like this c/o weekend post from K

Long read, please bare with me! A bit of back ground.

In mid August, the company updated its significant shareholders list.

The 2 that were there, have now gone, probably because their holding was diluted after the pathetic raise ( which still irks me )

A new name appeared " Gary Marshall " and yes, that name is i would add, quite a common name. So, it could be anyone of the 1000's of GM's in the UK or world.

Rightly or wrongly, i have looked for GM's working in the pharma industry. They should have a better understanding of what it is PYC are trying to do and accomplish especially within "Precision Medicine" and their so called "Dosing tool"

However, we know that 1 of the names now not on the list ( and believe to still be holding ) is Zahid Ali. He works for a pharma company ( UCB ) .

So after mentioning it last night, and some great insights from GordonBennet1 as to why it would not be 1 of the GM's i mentioned in another industry.

It leaves 2 GM's, both in pharma areas. 1 works for Repare Therapeutics, the other is a GM who works for PSC Biotech.

Doing some digging on PSC, https://biotech.com/ they help various companies in many sectors.

On their website, they can help with "Regulatory approval" https://biotech.com/service/regulatory-affairs/ & "engineering" https://biotech.com/service/engineering/

"Personalised Medicine " thou its a US site so Persoanilsed is with a Z instead of a S !https://biotech.com/service/

You are probably thinking what has this got to do with PYC?

PYC have their dosing tool, which has been used within Doseme for a few years now ( thou there is some conjecture on this ) It has long been mooted that they want to expand it & be more commercial, especially within the USA pharma field. To do this, their "tool" will need Regulatory approval, especially with the FDA, and PSC help with that. Also FDA have a new thing called "project optimus" & PYC are one of the 1st UK coys attempting to trail blaze this initiative.

PSC say they can help with software and many other things that can get a product off the ground.

There could also be the thorny issue that if this is the Gary Marshall that works for PSC, and has got wind of what PYC are planning to do, and could even be the project leader ( his role ) then how does he get 3,2% of PYC, would it be legal?

Zahid Ali went above 3% days after the Doseme or ( DosemeRx as it was ) deal was released, and although he was not involved in anyway, as a industry "insider" it is hypothosised he could see the benefits of it. Just a real shame that after 3 years, nothing has really come of it. ( THRC who owned Doseme, sold then last year )

Anyway, that is my line of thinking, and as i have said numerous times, clutching at straws, and 1 day i maybe right!

Well done LSE Admin, Davey is gone

Not only is Davey a troll but he is also blatant liar as I have never posted on the MBO thread or even about them.

I have reported his post to ADMIN to have him banned for blatant lying

davey50 Posts: 1,692 Price: 2.00 No Opinion RE: PriceToday 09:57

Oh dear the pump and dumpers are not very happy at the exposure, so they want to work together to get other people banned for exposing them.

Go and read the MBO thread and see what Ria and Newuncle are like, all over a thread then they vanish after the dumps

Good time to buy

I see Zak Mir covered Cornerstone over the weekend and remains bullish with a short term target of 13p

Usually his coverage is like a massive sell signal to the market (why I will never understand) but this time I think he's right in terms of gains to be had but wrong with his target upside which I believe could much more if the retail market focuses on the ridiculously cheap MCAP of £6m here v 1st half revenues of £3.6M, second half should be even higher for this fast growing business in very high value FX markets. DYOR but just look at CSFS peers values to see how cheap CSFS actually is today.

I don't often say this but you all need to report Petroinvestor posts using the report buttons on each and every one of his posts, he clearly is posting against PYC but doing it for purely personal reasons against RIA which is not acceptable, if you don't he will simply carry on disrupting the PBB.

PYC is clearly on a roll following several contract awards and this latest senior and significant appointment.

Petro is only posting here because he hates RIA, nothing else.

Yes gst is very much on the retail radar, right place, right time for fx stocks. Csfs plc have their interims out plus a meet investors session due 12 Sept and should be a very useful guide as to what's happening out there for anyone in fx related shares.

Good luck all

Good time to buy

Just look at yesterdays trades

Good time to buy

"The strong trading momentum experienced in 2022 has been sustained into the current year, and we remain on track for a significant increase in revenue for full year 2023 and are optimistic in terms of adjusted EBITDA positivity. As a result, and as we continue to broaden our partnership network and offer, we remain confident in the future and look forward to reporting on our progress."

Solid day

Moving Day as buyers come in, nice.